Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
367 participants in 2 patient groups
Loading...
Central trial contact
Marian Chelsea Evangelista; Benjamin Toll, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal